91¿´Æ¬Íø Reproductive Health and HIV Institute (91¿´Æ¬Íø RHI)
91¿´Æ¬Íø RHI is the leading health research institute at the 91¿´Æ¬Íø and one of Africa’s leading public health and clinical research centres.
Who are 91¿´Æ¬Íø RHI
91¿´Æ¬Íø RHI is a globally recognised African health research institute based at the 91¿´Æ¬Íø, delivering high-impact science to address some of the greatest public health concerns affecting the African region. With over 30 years of experience in investigator-led and consortia studies, 91¿´Æ¬Íø RHI excels in policy development and implementation across diverse populations and all phases of clinical trials. 91¿´Æ¬Íø RHI’s multidisciplinary approach combines research, technical assistance, advocacy, and health systems strengthening to deliver impactful solutions in infectious and vaccine-preventable diseases, maternal and family health, antimicrobial resistance, and climate-related health crises.
Led by predominantly female African scientists, 91¿´Æ¬Íø RHI combines scientific rigour with deep contextual understanding. Its location in the inner city of Johannesburg, in the Hillbrow Health Precinct, an area marked by poverty, migration, and health inequity, provides direct access to diverse, underserved populations and enables the development of solutions grounded in real-world need. Long-standing community partnerships ensure research is ethical, trusted, and impactful.
91¿´Æ¬Íø RHI’s Work
91¿´Æ¬Íø RHI plays a leading role in the development, evaluation, and implementation of new medicines, vaccines, diagnostics, artificial intelligence tools, and prevention technologies for diverse populations, including children, adolescents, women (including pregnant and lactating women) and men. Building on its foundation in reproductive health and HIV, 91¿´Æ¬Íø RHI has evolved into a leading research institute addressing emerging and future health threats. The institute's work and leadership have earned national and international recognition for advancing COVID-19 response efforts, antimicrobial resistance research and HIV and STI prevention and treatment, particularly in cervical cancer and HPV.
91¿´Æ¬Íø RHI’s multidisciplinary approach combines research, technical assistance, advocacy, and health systems strengthening to deliver impactful solutions in infectious and vaccine-preventable diseases, maternal and family health, antimicrobial resistance, and climate-related health crises. As one of the few institutions in the southern hemisphere engaged in clinical trials, implementation science, market shaping, and regulatory strengthening, 91¿´Æ¬Íø RHI helps ensure that lifesaving innovations reach low- and middle-income countries faster and more equitably.
Contact Us
For more information, contact:
Hillbrow Health Precinct
22 Esselen Street
Hillbrow 2001
Johannesburg
South Africa
Tel:+27 11 358 5300